{"schema_version":"1","generated_at":"2026-10-30T05:35:22.920Z","data_as_of":null,"url":"https://www.findmykol.com/kol/kadambari-vijaykumar","json_url":"https://www.findmykol.com/kol/kadambari-vijaykumar/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"kadambari-vijaykumar","name":"Kadambari Vijaykumar","credential":"MD","specialty":"Pulmonary Disease","specialty_raw":"Pulmonary Disease","therapeutic_area":"Respiratory","therapeutic_areas":["Respiratory"],"institution":"University of Alabama at Birmingham","institution_url":"https://www.findmykol.com/institution/university-of-alabama-at-birmingham","city":"Birmingham","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1861809360","orcid":"0000-0001-6924-4335","openalex":"A5029481066"},"summary":"Kadambari Vijaykumar is a Respiratory physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 40 publications with 523 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Respiratory"]},"scholarship":{"works_count":40,"cited_by_count":523,"h_index":10,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":4,"program_years":{"first":2021,"last":null},"rows_total":5,"shown":3,"withheld":2,"rows":[{"payer":"Viatris Specialty LLC","program_year":2025,"amount_usd":121.82,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861809360"},{"payer":"Insmed, Inc.","program_year":2025,"amount_usd":102.41,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861809360"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":102.46,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1861809360"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1861809360","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Respiratory","share_pct":43.3,"classes_total":1,"classes":[{"class":"beta2-Adrenergic Agonist","setting":"prescribed","share_pct":43.3,"drugs":[{"name":"Albuterol Sulfate Hfa","share_pct":50},{"name":"Serevent Diskus","share_pct":50}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":31.7,"classes_total":1,"classes":[{"class":"Macrolide Antimicrobial","setting":"prescribed","share_pct":31.7,"drugs":[{"name":"Azithromycin","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":25,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":25,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":5.3,"facility_pct":94.7},"source":"medicare"},"publications":{"total":47,"shown":5,"withheld":42,"matched_by":"OpenAlex author record","recent":[{"title":"Development of a novel potential difference probe with bedside validation simulator for potential difference testing","year":2026,"journal":"American Journal of Physiology-Lung Cellular and Molecular Physiology","source_url":"https://doi.org/10.1152/ajplung.00159.2025","status":"verified"},{"title":"241 Functional characterization of an ex vivo ferret model as a precursor for cell therapy","year":2025,"journal":"Journal of Cystic Fibrosis","source_url":"https://doi.org/10.1016/s1569-1993(25)01860-0","status":"verified"},{"title":"Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial","year":2024,"journal":"The Lancet Respiratory Medicine","source_url":"https://doi.org/10.1016/s2213-2600(24)00205-4","status":"verified"},{"title":"Ivacaftor for Chronic Obstructive Pulmonary Disease: Results from a Phase 2, Randomized Controlled Trial","year":2024,"journal":"American Journal of Respiratory and Critical Care Medicine","source_url":"https://doi.org/10.1164/rccm.202407-1302oc","status":"verified"},{"title":"Elexacaftor-Tezacaftor-Ivacaftor Improves Clinical Outcomes in Individuals with CF Encoding N1303K CFTR","year":2024,"journal":"SSRN Electronic Journal","source_url":"https://doi.org/10.2139/ssrn.4745080","status":"verified"}],"source":"works"},"contact":{"address_1":"1900 UNIVERSITY BLVD","city":"Birmingham","state":"AL","zip":"352943001","phone":"205-996-9598","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1861809360","source":"identity"},"similar":[{"name":"Suzanne Oparil","slug":"suzanne-oparil","institution":"University of Alabama at Birmingham","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/suzanne-oparil","json_url":"https://www.findmykol.com/kol/suzanne-oparil/profile.json"},{"name":"Richard Whitley","slug":"richard-whitley","institution":"University of Alabama at Birmingham","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/richard-whitley","json_url":"https://www.findmykol.com/kol/richard-whitley/profile.json"},{"name":"David Standaert","slug":"david-standaert","institution":"University of Alabama at Birmingham","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-standaert","json_url":"https://www.findmykol.com/kol/david-standaert/profile.json"},{"name":"Bruce Korf","slug":"bruce-korf","institution":"University of Alabama at Birmingham","specialty":"Clinical Genetics (M.D.)","url":"https://www.findmykol.com/kol/bruce-korf","json_url":"https://www.findmykol.com/kol/bruce-korf/profile.json"},{"name":"Fernando Martinez","slug":"fernando-martinez","institution":"University of Massachusetts Chan Medical School","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/fernando-martinez","json_url":"https://www.findmykol.com/kol/fernando-martinez/profile.json"},{"name":"David Gozal","slug":"david-gozal","specialty":"Pediatric Pulmonology","url":"https://www.findmykol.com/kol/david-gozal","json_url":"https://www.findmykol.com/kol/david-gozal/profile.json"},{"name":"Ronald Crystal","slug":"ronald-crystal","institution":"Weill Cornell Medicine","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/ronald-crystal","json_url":"https://www.findmykol.com/kol/ronald-crystal/profile.json"},{"name":"Bartolome Celli","slug":"bartolome-celli","institution":"Brigham and Women's Hospital","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/bartolome-celli","json_url":"https://www.findmykol.com/kol/bartolome-celli/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":2,"publications":42}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-06-28","provider_certified":"2021-10-12","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}